RBS Global Big Pharma ETN (DRGS) - NYSEARCA
DRGS is defunct since July 7, 2015. Lack of investor interest
DRGS Description
The RBS Global Big Pharma ETNs are designed for investors who seek exposure to the NYSE Arca Equal Weighted Pharmaceutical Total Return Index (the “Index”). The Index is designed to track the performance of the equity securities of a cross section of companies involved in various phases of development, production and marketing of pharmaceuticals, with the component securities represented in approximately equal dollar amounts. The Index is rebalanced quarterly at the close of trading on the third Friday of March, June, September and December.
See more details on sponsor's website
Sector: Healthcare
Find the right ETFs for your portfolio: Visit Seeking Alpha's ETF Hub